Literature DB >> 9242796

Guidelines on drug treatments for Alzheimer's disease.

S Lovestone1, N Graham, R Howard.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9242796     DOI： 10.1016/S0140-6736(05)62221-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Care of older people: Mental health problems.

Authors:  A Burns; T Dening; R Baldwin
Journal:  BMJ       Date:  2001-03-31

2.  The dilemma of new drugs. Are costs rising faster than effectiveness?

Authors:  J Mason; N Freemantle
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

Review 3.  Donepezil: a review of its use in Alzheimer's disease.

Authors:  M Dooley; H M Lamb
Journal:  Drugs Aging       Date:  2000-03       Impact factor: 3.923

Review 4.  Donepezil. Pharmacoeconomic implications of therapy.

Authors:  R H Foster; G L Plosker
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

Review 5.  The cholinergic hypothesis of Alzheimer's disease: a review of progress.

Authors:  P T Francis; A M Palmer; M Snape; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

6.  Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice.

Authors:  Anna Fiorentini; Maria Cristina Rosi; Cristina Grossi; Ilaria Luccarini; Fiorella Casamenti
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.